A joint mission by the World Health Organization and the Republic of Korea's Ministry of Health and Welfare to review the situation regarding the outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) in the Republic of Korea, has begun its work with an open and candid exchange of information and experience. Initial recommendations provided by the joint mission have been welcomed by the government.
The mission, which began yesterday in Seoul, is assessing the epidemiological pattern of MERS-CoV in the Republic of Korea as well as the characteristics of the virus and clinical features. It is also reviewing the public health measures implemented to date.
Dr. Keiji Fukuda, World Health Organization (WHO) assistant director-general for health security, who is co-leading the mission together with Dr. Jong-Koo Lee, director of the Center for Global Medicine at Seoul National University, said that interactions in early discussions had been excellent. “The exchange of information and experience has included the provision of detailed information about the outbreak and the control measures that have been put into place, as well as discussion of existing challenges,” he says.
Fukuda adds that current efforts to control the outbreak and prevent further spread are being intensified. WHO has been working closely with the Ministry of Health and Welfare and the Korea Centres for Disease Control and Prevention on response measures since the outbreak began.
There have been 108 confirmed cases of MERS CoV (including one confirmed case in China) reported in the Republic of Korea so far, with nine deaths. Whenever an emerging pathogen like the MERS virus appears in a new setting, for example, in a new country, a timely and thorough investigation is critical, particularly to assess whether the virus and its transmission are changing, and to ensure implementation of the most appropriate control strategies.
The evidence presented thus far suggests that the pattern of the outbreak in the Republic of Korea may be similar to MERS outbreaks that have taken place in healthcare facilities in the Middle East. However, the situation is rapidly evolving and investigations are ongoing.
The initial recommendations made today by the joint mission are:
- Infection prevention and control measures should immediately be strengthened in all facilities across the country.
- All patients presenting with fever or respiratory symptoms should be asked about: contact with a MERS patient; visits to a health care facility where a MERS patient has been treated; and history of travel to the Middle East in the 14 days before symptom onset. Any patient with positive responses should be promptly reported to public health authorities and managed as a suspected case while the diagnosis is being confirmed.
- Close contacts of MERS cases should not travel during the period when they are being monitored for the development of symptoms.
- Strong consideration should be given to re-opening schools, as schools have not been linked to transmission of MERS-CoV in the Republic of Korea or elsewhere.
The joint mission will end its in-country visit on June 13.
Source: WHO
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.